No evidence for a genetic modifier for renal cell cancer risk in HLRCC syndrome.
Vahteristo P, Koski TA, Näätsaari L, Kiuru M, Karhu A, Herva R, Sallinen SL, Vierimaa O, Björck E, Richard S, Gardie B, Bessis D, Van Glabeke E, Blanco I, Houlston R, Senter L, Hietala M, Aittomäki K, Aaltonen LA, Launonen V, Lehtonen R.
Vahteristo P, et al.
Fam Cancer. 2010 Jun;9(2):245-51. doi: 10.1007/s10689-009-9312-2.
Fam Cancer. 2010.
PMID: 20091131